Study Points
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
Study Points
Click on any objective to view test questions.
- Identify emerging trends in drug therapy and their place in patient care practices
- List diabetes medications with cardiovascular benefit by reducing major adverse cardiovascular events (MACE) or heart failure hospitalizations.
- Discuss considerations for safe use of SGLT2 inhibitors and GLP-1 agonists.
Which class of diabetes medications has shown cardiovascular benefit by reducing major adverse cardiovascular events (MACE)?
Which medication has been shown to reduce heart failure hospitalizations?
Which complication is associated with giving a GLP-1 agonist too close to a procedure or surgery?
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.